Daisuke Usui
Fortune : 201 421 $ au 30/06/2026
Fortune : 201 421 $ au 30/06/2026
Daisuke Usui currently works at ReproCELL, Inc., as Chief Operating Officer & Director from 2020, RC Partners, Inc., as Director from 2016, ReproCELL Europe Ltd., as Director from 2016, and MAGiQ Therapeutics KK, as Director from 2019.
Mr. Usui also formerly worked at Reinnervate Ltd., as Chief Executive Officer.
Mr. Usui received his undergraduate degree from the University of Tsukuba.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
REPROCELL INC. 0,27 % | 31/03/2025 | 264 000 ( 0,27 % ) | 201 421 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| REPROCELL INCORPORATED | Directeur des opérations | 11/11/2020 |
RC Partners, Inc.
RC Partners, Inc. Investment ManagersFinance Engages in the operation and management of investment funds | Directeur/Membre du Conseil | 01/06/2016 |
ReproCELL Europe Ltd.
ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a human tissue research facility | Directeur/Membre du Conseil | 01/07/2016 |
MAGiQ Therapeutics KK
MAGiQ Therapeutics KK Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Directeur/Membre du Conseil | 01/12/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
Reinnervate Ltd.
Reinnervate Ltd. BiotechnologyHealth Technology Operates as a life sciences company which manufactures and distributes three dimensional cell culture products | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
University of Tsukuba
University of Tsukuba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reinnervate Ltd.
Reinnervate Ltd. BiotechnologyHealth Technology Operates as a life sciences company which manufactures and distributes three dimensional cell culture products | Health Technology |
ReproCELL, Inc.
ReproCELL, Inc. Medical SpecialtiesHealth Technology Engages in the reagents for ES/iPS and stem cell-derived functional cells | Health Technology |
RC Partners, Inc.
RC Partners, Inc. Investment ManagersFinance Engages in the operation and management of investment funds | Finance |
ReproCELL Europe Ltd.
ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a human tissue research facility | Commercial Services |
MAGiQ Therapeutics KK
MAGiQ Therapeutics KK Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national